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Abstract: Metabotropic GABAB receptors are known to modulate the activity
of voltage-dependent calcium channels. Previously, we have shown that
GABAB receptors couple to a non-Gi/o G-protein to enhance calcium influx
through L-type calcium channels by activating protein kinase C in neonatal rat
hippocampal neurons. In this study, the components of this signaling pathway
were investigated further. Gαq was knocked down using morpholino
oligonucleotides prior to examining GABAB-mediated enhancement of calcium
influx. When Gαq G-proteins were eliminated using morpholino-mediated
knockdown, the enhancing effects of the GABAB receptor agonist baclofen
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(10 μM) on calcium current or entry were eliminated. These data suggest that
GABAB receptors couple to Gαq to regulate calcium influx. Confocal imaging
analysis illustrating colocalization of GABAB receptors with Gαq supports this
hypothesis. Furthermore, baclofen treatment caused translocation of PKCα
(protein kinase C α) but not PKCβ or PKCε, suggesting that it is the α isoform
of PKC that mediates calcium current enhancement. Inhibition of
calcium/calmodulin-dependent kinase II did not affect the baclofen-mediated
enhancement of calcium levels. In summary, activation of GABA B receptors
during development leads to increased calcium in a subset of neurons through
Gαq signaling and PKCα activation without the involvement of
calcium/calmodulin-dependent kinase II.

Activation of GABAB receptors in the neonatal rat hippocampus enhances
voltage-dependent calcium currents independently of Gi/o. In this study,
knockdown of Gαq with morpholino oligonucleotides abolished enhancement of
calcium influx and protein kinase Cα was activated by GABAB receptors.
Therefore, we hypothesize that GABAB receptors couple to Gq to activate PKCα
leading to enhancement of L-type calcium current.
Abbreviations used
Ant-AIP-II Antennapodia sequence-fused autocamtide-2 related inhibitory
peptide II
CaMKII calcium/calmodulin-dependent protein kinase 2
CREB cAMP response element-binding protein
DAG diacylglycerol
ERK1/2 extracellular signal-regulated kinase 1/2
GIRK G-protein coupled inwardly rectifying potassium channel
IIntide myristolated calmodulin kinase IINtide
IOD integrated optical density
IP3 inositol trisphosphate
KCTD potassium channel tetramerization domain
PCC Pearson's correlation coefficient
PIP2 phosphatidylinositol 4,5-bisphosphate
PKA protein kinase A
PKC protein kinase C
ROI region of interest
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GABAB receptors are members of a large group of class C 7
transmembrane G-protein coupled receptors, sharing structural
similarities with metabotropic glutamate receptors (Kaupmann et al.
1997). Uniquely, these receptors form heteromers, composed of a
GABAB1 and GABAB2 subunit, which dimerize within the ER to be
trafficked to the cell membrane. While there are allosteric interactions
between the subunits during activation, the ligand binds the GABAB1
subunit, and the G-protein interacts with GABAB2. Functionally, GABAB
receptors may be either pre- or post-synaptic, and their activation is
considered inhibitory via coupling to Gαi/o G-proteins. There are three
well-described mechanisms of this inhibition: first, the α subunit of
Gαi/o signaling inhibits adenylyl cyclase, reducing cAMP levels and/or
protein kinase A (PKA) activation (Nishikawa et al. 1997). Second,
calcium channels are directly inhibited by the βγ subunit. This reduces
pre-synaptic neurotransmitter release and post-synaptic dendritic
calcium spikes (Chalifoux and Carter 2011). Finally, GABAB receptor
stimulation activates G-protein-coupled inwardly rectifying potassium
channels, again through direct interaction with the βγ subunit
(Reuveny et al. 1994; Wickman et al. 1994). In this case, potassium
efflux generates inhibitory post-synaptic potentials which hyperpolarize
the cell.
While cases of GABAB receptor activation leading to inhibition
have been well documented, there are reports demonstrating an
enhancement of voltage-dependent calcium channel activity (Shen and
Slaughter 1999; Carter and Mynlieff 2004; Bray and Mynlieff 2009,
2011; Park et al. 2010; Im and Rhim 2012). In the hippocampus,
long-lasting (L-type) current is facilitated in a subset of cells when
GABAB receptors were activated by the GABAB receptor-specific ligand
baclofen (Carter and Mynlieff 2004). This phenomenon is observed
early in development, peaking at postnatal day 6 (P6) to P8 in rats
(Bray and Mynlieff 2009). Furthermore, this GABAB receptor-mediated
enhancement of calcium current was not sensitive to pertussis toxin, a
known inhibitor of Gαi/o-mediated processes (Bray and Mynlieff 2011).
Our laboratory demonstrated that this enhancement is dependent on
protein kinase C (PKC) activation. Enhancement of calcium current was
eliminated when global PKC inhibitors were used and treatment of cells
with the PKC activator phorbol 12-myristate 13-acetate (PMA)
mimicked the effect of activating GABAB receptors. However,
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participants in the signaling pathway, such as specific G-proteins and
isoforms of PKC, have not been previously investigated.
This study sought to identify components of the GABAB receptor
mediated increase in calcium current. Because the effect of calcium
current enhancement was not sensitive to pertussis toxin, we
hypothesized that GABAB receptors may couple to another G-protein
besides Gαi/o. It is not likely a Gαs G-protein, because this pathway
initiates PKA signaling. Instead, we hypothesized that the G-protein
involved in this signaling pathway was a member of the Gαq family of
G-proteins (Gαq, Gα11, Gα14, Gα15/16), which are known to activate PKCs
through activation of phospholipase Cβ. To test this hypothesis, a
morpholino-induced knockdown strategy was used to inhibit signaling
of specific G-proteins.
Next, the identity of the specific isoform of PKC that is involved
in the signal transduction pathway was investigated. There are at least
15 isoforms of PKC, separated into three families based on their
requirements for activation. Conventional PKCs require calcium ions,
diacylglycerol (DAG), and a phospholipid such as phosphotidylserine.
Novel PKCs require DAG and a phospholipid, but not calcium ions;
atypical PKCs require neither DAG nor calcium ions for activation. As
PMA treatment mimics GABAB receptor activation, the isoform was not
likely to be atypical. Furthermore, the highest proportion of neurons
demonstrating current enhancement occurs at P7. Different PKC
isoforms demonstrate different temporal expression, so those isoforms
which are highly expressed at P7, and also not of the atypical family,
were examined using translocation to the membrane as a measure of
activation.
Finally, the involvement of calcium/calmodulin-dependent
kinase II (CaMKII) as a component of the signaling cascade was
investigated. It has been shown previously that CaMKII is required in
other G-protein pathways which result in calcium current enhancement
(O-Uchi et al. 2008). In addition, CaMKII is known to phosphorylate Lchannels, thereby increasing current (Hudmon et al. 2005; Abiria and
Colbran 2010). Thus, we hypothesized that PKC may activate CaMKII,
which in turn phosphorylates the calcium channel. Results presented
here provide evidence that the GABAB receptor couples to Gαq in
neonatal hippocampal neurons, causing PKCα to translocate to the cell
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membrane, where it putatively interacts with L-type calcium channels,
bypassing the involvement of CaMKII.

Methods
Isolation of hippocampal neurons
All animal protocols were approved by the Marquette University
Institutional Animal Care and Use Committee according to guidelines
set forth by the National Research Council in the Guide for the Care
and Use of Laboratory Animals. Hippocampal neurons were obtained
from P6–P8 Sprague–Dawley rat pups of either sex (Onsite breeding
colony, parents from Charles River Laboratories; Mynlieff 1997).
Briefly, pups were anesthetized with 100% CO2 and decapitated. Using
sterile technique, the superior regions of the hippocampi were
dissected, diced, and incubated in oxygenated PIPES-buffered saline
with 0.5% Trypsin XI and 0.01% DNase I (Sigma-Aldrich, St. Louis
MO, USA). After a 30 min incubation at 22°C the tissue was placed in a
35°C water bath for 60 min. After a series of rinses, the tissue was
triturated and the cell suspension was plated onto poly-l-lysine coated
dishes or glass coverslips (MW 38 500–60 000; Sigma Aldrich) and
transferred to a 37°C 5% CO2 water-jacketed incubator. Cultures were
maintained a minimum of 20 h before experiments to allow recovery
from enzymatic digestion.

Protein knockdown
Knockdown of Gαq G-proteins in neuronal cultures was
performed with morpholinos delivered by the Endo-Porter delivery
system (Gene Tools LLC, Philomath, OR, USA). Morpholino
oligonucleotides were designed to sterically inhibit translation of Gαq
mRNA (Entrez ID: 13591956 NM_031036,
5′ACGCCATGATGGACTCCAGAGTCAT); negative nonsense controls
(5′AAACCCGGGTTTACG) were used to insure specificity of the target
oligo. Morpholinos were synthesized with a 3′ carboxyfluorescein tag
to visualize delivery. Endo-Porter peptide (final concentration 4 μM)
and morpholino oligos (final concentration 2 μM) were added one time
to the Neurobasal-A media in the culture dishes immediately after
dissociation of the cells. Delivery of oligos and cell viability was
Journal of Neurochemistry, Vol 135, No. 1 (October 2015): pg. 88-100. DOI. This article is © Wiley and permission has
been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to
be further copied/distributed or hosted elsewhere without the express permission from Wiley.

5

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

assessed at 24, 48, and 96 h post delivery to insure cargo was
delivered and cell health was not negatively impacted.

Western blot analysis
Whole hippocampal tissue or neurons from hippocampal cultures
were obtained from rat pups age P6–P8. For whole tissue samples,
hippocampi were dissected and homogenized in ice-cold buffer with
protease inhibitors (250 mM sucrose, 10 mM Tris, 10 mM HEPES,
1 mM EDTA, 1 μg/mL pepstatin, 1 μg/mL leupeptin, 0.5 mg/mL
Pefabloc; Sigma Aldrich; pH 7.2 with HCl) followed by centrifugation at
3287 g for 10 min at 4°C. The supernatant was centrifuged at 41473 g
for 30 min at 4°C, and the pellet was re-suspended in buffer and
stored at −80°C. For cultured cell samples, neurons were scraped from
culture dishes in homogenization buffer with protease inhibitors. The
sample was centrifuged at 25401 g for 10 min at 4°C, and the pellet
was re-suspended in 5% of the original volume of buffer to
concentrate the sample. The suspension was centrifuged at 3287 g for
10 min, the supernatant was retained, and centrifuged at 41473 g for
30 min. The pellet was re-suspended in 15% of the original volume of
homogenization buffer and stored at −80°C. Protein concentrations
were measured at 280 nm with a Biophotometer (Eppendorf, Enfield,
CT, USA).
NuPAGE® lithium dodecyl sulfate sample buffer and reducing
agent (Life Technologies, Carlsbad CA, USA) were added to protein
samples and the mixture was heated at 70°C for 10 min. The protein
samples were run on a NuPAGE® Novex 12% Bis-Tris minigel and
transferred to a polyvinylidene difluoride membrane (0.45 μM pore
size) using NuPAGE® transfer buffer (Life Technologies). Membranes
were washed with phosphate-buffered saline (PBS, 134.4 mM NaCl,
4.36 mM KCl, 10.56 mM NaHPO4, 1.66 mM NaH2PO4, pH to 7.4 with
HCl) and blocked for 2 h in PBS containing 0.05% Tween, 5% non-fat
dry milk, and 0.1% bovine serum albumin at 22°C. Proteins on
membranes were labeled with polyclonal rabbit anti-Gαq (anti-GNAQ,
1 : 500-1 : 1000, GeneTex catalog# GTX114029, Irvine CA, USA) or
polyclonal rabbit anti-Gα11 (1 : 500, GeneTex catalog# GTX118876) in
blocking solution. After a 90 min wash in PBS with 0.05% Tween,
membranes were incubated with goat anti-rabbit horseradish
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peroxidase-conjugated secondary antibody (1 : 1000-1 : 2500, Pierce,
Rockford IL, USA). The SuperSignal West Dura Extended Duration
chemiluminescent enhancement kit (Pierce) was used to visualize the
protein bands. The amount of protein loaded was verified by labeling
the membranes with anti-β-tubulin antibodies (1 : 2000, Cell
Signaling, Danvers MA, USA). Quantification of bands was performed
by measuring the integrated optical density (IOD) for each band using
Labworks 4.6 software (UVP, Upland CA, USA). In experiments where
expression was knocked down, data were normalized by dividing the
IOD of the band labeled with anti-G-protein antibodies with the IOD of
the band in the same lane visualized with anti-β-tubulin antibodies.

Electrophysiology
Calcium currents were measured in whole cell voltage clamp
mode using a Dagan 3900A patch clamp amplifier (Dagan Corporation,
Minneapolis MN, USA), Digidata 1322A acquisition setup, and pClamp
10.0 software (Molecular Devices, Sunnyvale CA, USA). Extracellular
recording solution (pH 7.4 with CsOH, 310–320 mOsm/L) contained
10 mM CaCl2, 145 mM tetraethylammonium chloride, 10 mM HEPES,
and 1 μM tetrodotoxin (Tocris Bioscience, Ellisville MO, USA).
Recording electrodes were pulled from borosilicate glass on a
Flaming/Brown Micropipette Puller (model P87, Sutter Instrument Co.,
Novato CA, USA) to a resistance of 5–9 MΩ and filled with intracellular
solution (140 mM Cs-aspartate, 5 mM MgCl2, 10 mM Cs2EGTA, 10 mM
HEPES, 2 mM ATP-Na2, and 0.1 mM guanosine triphosphate; pH 7.4
with CsOH, 300–310 mOsm/L). Cells were held at −80 mV and
depolarized to +10 mV with a 300 ms pulse. Whole cell currents were
electronically filtered at 1 kHz and digitized at 2 kHz. Linear
components of leak current were subtracted post hoc by the passive
resistance protocol in pClamp 10.0. The GABAB agonist (RS)-baclofen
(Tocris Bioscience) was dissolved in HCl, diluted 1 : 1000 in recording
solution to a final concentration of 10 μM and applied to neurons using
a U-tube delivery system constructed with PE-10 polyethylene tubing
housed in a glass tube. In experiments designed to test the effect of
CaMKII inhibition, CaMKII inhibitors cell permeable autocamtide-2
related inhibitory peptide (Ant-AIP-II, IC50 4 nM, catalog#189485,
EMD Millipore, Billerica, MA, USA; Ishida et al. 1998) or myristolated
calmodulin kinase IINtide (IINtide, IC50 50 nM, catalog#208921, EMD
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Millipore; Chang et al. 1998) were also added to the baclofen solution
and delivered via U-tube.
Calcium current measurements were taken at the end of the
300 ms depolarizing pulse to maximize the contribution of L-type
channels to the total current while minimizing the contribution of Nand P/Q-type channels. A graph of elicited sustained current
magnitude versus time was plotted, and a linear regression with 95%
confidence interval was constructed to account for run-up or run-down
of calcium current (Carter and Mynlieff 2004; Bray and Mynlieff 2011).
A cell that showed an increase or decrease in sustained calcium
current in response to baclofen displayed a current magnitude that fell
outside the confidence interval.

Calcium imaging
Cultured neurons were incubated for 1 h in the dark at 22°C in
calcium imaging Ringer's solution (CIR, 154 mM NaCl, 5.6 mM KCl,
1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 11 mM glucose, pH 7.4 with
NaOH) with 5 μM Fura-2 acetoxymethyl ester (Fura-2 AM, Life
Technologies). Cells were rinsed and incubated for 30 min at 22°C in
CIR without FURA-2 AM to allow for de-esterification. Neurons were
depolarized by perfusion of a high potassium solution (100 mM NaCl,
50 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 11 mM glucose,
pH to 7.4 with NaOH) to open voltage-gated calcium channels.
Baclofen (10 μM) in CIR was perfused onto the cells for 15 s, followed
by baclofen in high potassium solution for 30 s. CaMKII inhibitors were
added to the CIR/baclofen solution for pre-treatment, then added to
the high potassium/baclofen solution and applied via gravity. The
fluorophore was excited at 340 and 380 nm, and emissions were
measured at 510 nm using Slidebook 5.0 software (Intelligent
Innovations, Denver CO, USA).
To determine inherent variability of the system, a group of
control neurons were treated with high potassium solution three
consecutive times (N = 309). Response #1 and #3 were averaged as
the ‘control’ and the percent change with response #2 was calculated
as the ‘pseudo’ drug response. The response to the second application
of high potassium gave an average of 101.5 ± 13.20 (standard
deviation) percent change when compared with the average of the
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responses to application #1 and #3. During experiments, neurons
were stimulated three times; the first and third stimulations were high
potassium alone, and the middle stimulation was high potassium with
another agent. To determine the effect of agent application during
stimulation 2, its value was compared to the averaged value of
stimulations 1 and 3 (high potassium control stimulations). The
percent change with agent treatment when compared with the
averaged before and after values was classified as an increase or
decrease for a particular cell if the percent change with baclofen in
50 mM potassium solution was > 2 times the standard deviation
(2 × 13.20) of the cellular response from the control neurons
stimulated three times consecutively with high potassium solution
alone.

Immunostaining
To analyze the colocalization of GABAB receptors and Gαq,
hippocampi from P6 to P8 rats were dissected, fixed, frozen and sliced
into 20 μm sections. Sections were permeabilized with 0.5% Triton X100 in PBS for 20 min and blocked with 10% goat serum (Invitrogen,
Carlsbad, CA, USA) in PBS with 0.05% Triton X-100. The sections were
incubated for 2 h with polyclonal rabbit anti-GNAQ (1 : 1000, Genetex
catalog# GTX114029) and monoclonal mouse anti-GABABR1 (1 : 15,
UC Davis Neuromab, catalog# 73-183, Davis, CA, USA) in PBS with
0.05% Triton X-100 and 0.1% goat serum. After rinsing, sections were
incubated with Dylight® 488-conjugated goat anti-rabbit IgG and
Dylight® 550-conjugated goat anti-mouse IgG (Thermo Scientific,
Rockford, IL, USA) in PBS with 0.05% Triton X-100 and 0.1% goat
serum. After rinsing, mounting medium with DAPI (4′,6-diamidino-2phenylindole; Vector Laboratories, Burlingame, CA, USA) was applied
to stain nuclei; the sections were covered with a glass coverslip and
sealed. Sections were imaged with a Nikon Perfect Focus Ti-E confocal
microscope and NIS Elements imaging software (Nikon Instruments,
Melville, NY, USA).
To quantify the colocalization of GABAB receptors and Gαq Gproteins, regions of interest (ROI's) in the stratum oriens, pyramidal
cell layer, and stratum radiatum were drawn for each image. A
Pearson's correlation coefficient (PCC) was determined to quantify the
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degree of colocalization of the two proteins in each ROI. The PCC
measures overlap of pixels for the two fluorophores; the higher the
PCC, the more likely that the two proteins are overlapping in that ROI.
A PCC was determined for the 3 ROI's in each image (16 sections
taken from three animals), then averaged across sections, such that
there was a single PCC value for the stratum oriens, pyramidal cell
layer, and stratum radiatum, respectively.
To analyze the translocation of PKC, neuronal cultures were
treated with 1 μM phorbol-12-myristate-13 acetate (PMA, Calbiochem,
La Jolla CA, USA) or 10 μM baclofen for 10 min prior to fixation. Cells
were fixed in a solution of 4% paraformaldehyde in PBS for 30 min at
22°C, permeabilized in PBS with 0.5% Triton X-100 for 20 min and
blocked with 10% goat serum in PBS with 0.05% Triton X-100 for
45 min. The cells were incubated with either monoclonal rabbit antiPKCα (1 : 500 dilution, catalog# GTX61153, Genetex), polyclonal
rabbit anti-PKCβ (1 : 200 dilution, catalog# E021184, EnoGene
Biotech Co., Ltd., New York, NY, USA) or polyclonal rabbit anti-PKCε
(1 : 1000 dilution, catalog# GTX 109028, Genetex) overnight at 4°C.
Following two washes with PBS and 0.05% Triton X-100, cells were
incubated with Dylight® 488-conjugated goat anti-rabbit secondary
antibodies (1 : 500 dilution) for 1 h at 22°C. Mounting medium with
DAPI was applied for visualization of nuclei, and cells were imaged on
a Nikon Perfect Focus Ti-E confocal microscope and NIS Elements
imaging software (Nikon Instruments).

Statistics
Comparisons of the number of cells that exhibited either
enhancement of calcium entry with ratiometric imaging or
enhancement of calcium current with electrophysiology in cells treated
with morpholinos or CaMKII inhibitors were analyzed by a Chi-squared
test. A one-way anova was performed on PCC values obtained for the
different regions of the hippocampus using confocal image analysis of
protein colocalization followed by Holm–Sidak pairwise comparisons.
Differences in the number of cells demonstrating translocation of
different PKC isoforms were analyzed with Fisher's exact test.

Journal of Neurochemistry, Vol 135, No. 1 (October 2015): pg. 88-100. DOI. This article is © Wiley and permission has
been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article to
be further copied/distributed or hosted elsewhere without the express permission from Wiley.

10

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Results
Morpholino oligos inhibit Gαq protein expression
To verify that morpholino oligos were able to penetrate the cell
membrane and were not detrimental to cell viability, cultures were
treated with Endo-Porter and fluorescein-labeled morpholinos and
examined after 24, 48, and 96 h of incubation. Figure 1a shows
cultures after 96 h treatment. Cells maintained their characteristic
shapes and exhibited growing processes. Figure 1b illustrates that
essentially every cell exhibited some level of cytoplasmic fluorescence.
Although fluorescence levels vary, no punctate fluorescence is seen,
which would indicate morpholinos unable to exit endosomes. Visible
fluorescence requires ten-fold higher concentrations of morpholino
than are necessary to produce significant protein knockdown (Genetools, 2015). At concentrations ≥ 4 μM of oligos or ≥ 6 μM EndoPorter, morpholinos began to negatively affect growth and viability of
neuronal cultures (data not shown). Thus, 2 μM morpholino and 4 μM
Endo-Porter were used in all experiments. To determine the
effectiveness of morpholino-induced protein knockdown, neurons were
treated with Endo-Porter alone, nonsense morpholinos, or morpholinos
against Gαq and western blotting was performed at various time points
after the treatment. Figures 1c and d show the timecourse of Gαq
knockdown. As demonstrated in Fig. 1d, preparations treated for 48 h
with morpholinos against Gαq appeared to have less Gαq than
preparations treated with nonsense morpholinos. Cultures treated with
Endo-Porter alone or nonsense morpholinos demonstrated normal
levels of Gαq protein expression (e.g., see inset in Fig. 1d). Thus, using
the Endo-Porter delivery system, Gαq protein expression in neuronal
cultures was reduced without negatively impacting cell health or
viability. As a result of the relatively long half-life of G-proteins
(Derrien et al. 1996), all electrophysiological and calcium imaging
experiments were performed following 48 h incubation with Gαq
morpholinos to insure sufficient protein knockdown.
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Figure 1. (a) Differential interference contrast image of a hippocampal culture from a
postnatal day 4 rat pup treated with 10 μM control morpholino oligos and 2 μM EndoPorter peptide, and maintained in culture for 96 h. (b) Fluorescent image of (a); oligos
were tagged with carboxyfluorescein for visualization. (c) Western blot of proteins
isolated from either a control culture (lane 1), a culture treated for 24 h (lane 2) or
48 h (lane 3) with 2 μM Gαq oligos. Protein bands were visualized with Gαq antibodies
and β-tubulin antibodies as a loading control. Gαq band densities were calculated by
dividing the integrated optical density (IOD) of the Gαq band by the IOD of the β
tubulin band to control for loading and expressed as percent of control. (d) Western
blot analysis of six different preparations from cultured neurons treated for 48 h with
nonsense oligos (N = 3, NS MO) or Gαq oligos (N = 3, Gq MO). The data were
analyzed as in (c), with the average of the nonsense oligo-treated preparations
defined as 100%. Data are expressed as mean ± SEM. The inset is an example of Gαq
expression in control tissue compared to cells treated with nonsense morpholinos to
demonstrate that the nonsense morpholinos do not cause non-specific knockdown of
Gαq. (e) Western blot analysis of Gαq and Gα11 G-protein in the neonatal hippocampus.
Analysis was performed using tissue from the superior region of the hippocampus and
antibodies against either Gαq or Gα11 proteins. The left panel shows molecular weight
markers (same experiment but exposed to film for 1 s). To visualize bands labeled
with Gα11 antibody, 10 times more protein was loaded (right panel) than for lanes
labeled with Gαq antibodies (center panel) and the exposure time was increased to
10 min, compared with 3 min exposure for bands labeled with Gαq antibodies.

Gαq protein is more highly expressed than Gα11 in
neonatal hippocampus
Gα11 shares 90% sequence similarity with Gαq, and both Gproteins have a ubiquitous distribution pattern (Mizuno and Itoh
2009). Therefore, it was important to determine whether there could
be non-specificity in the morpholino knockdown of Gαq that may
decrease Gα11 as well. Protein preparations from cultured cells treated
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with Gαq or nonsense morpholinos were analyzed by western blotting
using Gα11 antibodies. If the morpholinos were specific to Gαq, there
would be no change in the level of Gα11. However, no Gα11 signal was
detected, even in control cultures not treated with morpholinos or
Endo-Porter (data not shown). This result was suggestive that either
the basal level of Gα11 was too low to detect with western blotting in
preparations of cultured neurons, or that the Gα11 antibody did not
recognize its target. To determine if the Gα11 antibody could recognize
Gα11 G-protein, protein samples were prepared from the superior
region of fresh whole hippocampus so that the amount of protein
loaded on the gel could be increased. The Gα11 antibody recognizes its
target, but only if 10 times the amount of protein was loaded and the
membrane was exposed to film for a longer period of time (Fig. 1e).
When a lane loaded with 2 μg of protein was probed with Gαq
antibody, the IOD was 7.2. When a lane loaded with 20 μg of protein
was probed with Gα11 antibody, the IOD was 5.0 on the same film at
the same exposure. These data suggest that the Gαq antibody
recognizes its protein target without detecting any Gα11 protein. Thus,
while it cannot be ruled out that the Gαq morpholino may nonspecifically knock down Gα11 G-protein, a more likely explanation is
that while both G-proteins are present, only Gαq G-protein is knocked
down.

Inhibiting Gαq expression abolishes baclofen-mediated
enhancement of voltage-dependent calcium entry or
current
Despite a lack of precedence for the GABAB receptor coupling to
a Gαq family member, downstream actions, including PKC activation,
were consistent with the actions of a Gαq type G-protein. Therefore,
we chose to knock down Gαq and assess whether application of the
GABAB receptor agonist baclofen (10 μM) could still lead to calcium
current enhancement. Hippocampal neurons were treated with either
nonsense or Gαq morpholinos, and enhancement of calcium entry or
current was assessed with calcium imaging and electrophysiology. In
the nonsense morpholino-treated cells, 6 of 64 cells (9.37%)
demonstrated an enhancement of high potassium induced calcium
entry with baclofen treatment using calcium imaging (Fig. 2a). Of the
207 cells treated with Gαq morpholinos, no cells demonstrated an
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enhancement of high potassium-induced calcium entry with baclofen
(Fig. 2c, Chi square, p < 0.001). Electrophysiology verified this result;
in control cells treated with nonsense oligos, 3 of 25 cells
demonstrated an enhancement of sustained calcium current when
baclofen was applied (Fig. 2b). In contrast, no cells of 15 treated with
Gαq morpholino oliogos for 48 h showed any calcium current
enhancement (Fig. 2d). This set of experiments demonstrates that
knockdown of the Gαq G-protein abolished enhancement of calcium
current or entry upon GABAB receptor activation, linking a Gαq family
member to this pathway and thus the GABAB receptor itself.

Figure 2. Effect of 48 treatment with Gαq morpholino oligos on calcium entry in
hippocampal neurons. Neurons were treated for 48 h with nonsense morpholino oligos
(a and b) or Gαq morpholino oligos (c and d). (a and c) Increases in intracellular
calcium were measured with ratiometric calcium imaging and reported as the 340/380
ratio. Neurons were stimulated with high potassium, followed by a pre-treatment with
10 μM baclofen and baclofen in high potassium (see 'Methods'). Each colored line
represents a single cell. (b and d) Calcium currents were elicited by a 300 ms
depolarizing pulse to +10 mV from a holding potential of −80 mV in the absence
(green trace) and presence of 10 μM baclofen (red trace).
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GABAB receptors colocalize with Gαq G-proteins
When hippocampal sections were labeled with anti-GABAB
receptor antibodies (red), nearly all areas were labeled, with the
exception of the granule cells in the dentrate gyrus (Fig. 3a). At high
magnification, there was an absence of nuclear labeling with GABAB
antibodies, with a clear delineation between the nuclei and the labeling
(Fig. 3e and h). Antibodies against Gαq labeled cells within both the
pyramidal cell layer and the granule cell layer (Fig. 3b and f). In
addition, there appeared to be individual cell bodies labeled within the
stratum oriens and stratum radiatum without any diffuse labeling
throughout these layers, as seen with GABAB antibodies. At low
magnification, colocalization of the two fluorphores was most evident
in the pyramidal cell layer and is absent from the dentate gyrus
granule cell layer (see white arrows indicating pyramidal cell layer and
granule cell layer; Fig. 3c and d). Quantitative analysis done at high
magnification in the superior region of the hippocampus supports
qualitative evidence seen at low magnification (Fig. 3c and g). The
average Pearson's Correlation Coefficient (PCC), used to determine
colocalization, was 0.125 ± 0.03 (SEM) in the stratum oriens. The PCC
was 0.476 ± 0.03 in the pyramidal cell layer and 0.102 ± 0.01 in the
stratum radiatum. The colocalization of GABAB receptors and Gαq is
highest in the pyramidal cell layer, as suggested by the PCC value; the
PCC is significantly higher in the pyramidal cell layer than either the
stratum oriens or stratum radiatum (Fig. 3g; One-way anova followed
by Holm–Sidak pairwise comparison, p < 0.001). A small number of
neurons in both the stratum radiatum and the stratum oriens were
labeled by antibodies against Gαq, and some of these neurons also
appeared to be labeled with GABAB receptor antibodies (Fig. 3i,
arrowhead). These neurons had a relatively high (0.5–0.75) PCC
value. The functional significance or physiological identity of these
neurons is unknown.
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Figure 3. GABAB receptors colocalize with Gαq G-proteins in rat hippocampus.
Hippocampal sections were labeled with polyclonal rabbit anti-GNAQ and monoclonal
mouse anti-GABABR1 followed by Dylight® 488-conjugated goat anti-rabbit IgG
(green) and Dylight® 550-conjugated goat anti-mouse IgG (red) for visualization.
Nuclei were stained blue with DAPI. Colocalization of the red and green fluorophore
appears yellow in the merged images (c, d, g, h, and i). (a–d) Low magnification
images showing the whole section of hippocampus. (e–h) High magnification images
showing the pyramidal cell layer (P), the stratum oriens (O), or the stratum radiatum
(R). A small number of cells in both the stratum oriens and stratum radiatum
appeared to show colocalization of GABAB and Gαq with a high Pearson's correlation
coefficient (PCC) value. (i) Expansion of a high magnification image demonstrating
colocalization(white arrowhead). (j) control sections (high magnification) processed
without primary antibodies demonstrate autofluorescence of blood vessels. DG dentate
gyrus. Scale bar in panel (high magnification) J = 10 μm.

CaMKII activity is not involved in GABAB receptormediated increases in intracellular calcium
Cultured neurons were depolarized with 50 mM potassium
solution, followed by a 50 mM potassium solution containing both
10 μM baclofen and a cell permeable CaMKII inhibitor, Ant-AIP-II
(50 nM). Both baclofen and Ant-AIP-II were applied during a 15 s pretreatment period as well as during the high potassium application.
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Twenty-two of 255 (8.63%) cells imaged continued to demonstrate an
increased 340/380 ratio, despite the presence of the inhibitor. When
the inhibitor/baclofen solution was washed off, the response returned
to original levels (Fig. 4a). Because there have been reports of nonspecific actions of CaMKII inhibitors on voltage-dependent calcium
channels (Gao et al. 2006; Karls and Mynlieff 2013), the result was
confirmed using a second cell permeable inhibitor, IINtide (250 nM). A
similar result was obtained, where 47 of 432 (10.88%) neurons
showed a reversible increase in 340/380 ratio when baclofen was coapplied with IINtide (Fig. 4b). These values were not significantly
different from control cells treated with baclofen alone, where 46 of
392 (11.73%) of cells showed increases in the high potassiumstimulated 340/380 ratio (Fig. 4c, Chi square). Electrophysiological
recordings were performed in the presence and absence of 50 nM AntAIP-II and 10 μM baclofen. The calcium current enhancement
displayed when Ant-AIP-II was co-applied with baclofen was not
significantly different than that seen with baclofen alone (Fig. 4d). In
these experiments, 4 of 23 (17.39%) cells treated with Ant-AIP-II and
baclofen displayed a significant increase in calcium current. In control
cells, 6 of 27 (22.22%) displayed a significant increase when treated
with baclofen alone. Thus, since neither inhibitor blocked the
enhancement of calcium entry or current, it is likely that CaMKII is not
involved in the pathway where activation of GABAB receptors results in
increased calcium entry via L-type channels.

Figure 4. The increase in calcium entry as a result of GABAB receptor activation with
baclofen is not affected by calcium/calmodulin-dependent protein kinase 2 (CaMKII)
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inhibitors. Neurons were stimulated with high potassium, followed by a pre-treatment
with 10 μM baclofen with or without a CaMKII inhibitor followed by baclofen and
CaMKII inhibitor in high potassium for ratiometric calcium experiments. Each colored
line in (a and b) represents a single cell. Enhancement of calcium influx by baclofen
persists in the presence of CaMKII inhibitor Antennapodia sequence-fused
autocamtide-2 related inhibitory peptide II (Ant-AIP-II) (a, 50 nM) or myristolated
CaMKII inhibitor IINtide (b, 250 nM). Concentrations chosen were 5–10 fold higher
than the reported IC50 values. (c) There is no significant difference in number of cells
demonstrating a baclofen-mediated increase in calcium influx when either CaMKII
inhibitor is present in comparison to control cultures without (Chi square, total N is
inset in each bar). (d) Electrophysiological recording shows persistent calcium current
enhancement when baclofen (left) or baclofen and Ant-AIP-II (right) are present (red
line) compared to a control trace (green line).

PKCα translocates to the membrane upon GABAB
receptor activation
Analysis of immunohistochemical images with confocal
microscopy was utilized to determine whether PKCα, PKCβ, or PKCε
was translocated from the cytosol to the plasma membrane followed
by 10 min treatment of cultured hippocampal neurons with baclofen
(10 μM). A previous study demonstrated that activation of PKC by
phorbol esters mimicked the effect of GABAB receptor stimulation on
calcium currents in cultured hippocampal neurons (Bray and Mynlieff
2011). Therefore, only phorbol ester-sensitive isoforms of PKC that are
expressed in the early neonatal period were tested (Tanaka and
Nishizuka 1994; Roisin and Barbin 1997). Cells were either treated
with no drugs (unstimulated) or with the phorbol ester PMA (1 μM) to
verify that the translocation to the membrane was apparent in confocal
images. Fig. 5a demonstrates that both treatment with PMA and
baclofen caused translocation of PKCα from the cytosol to the plasma
membrane. A small percent of cells in each culture demonstrated
spontaneous translocation of all three isoforms of PKC examined in
unstimulated cultures (Fig. 5b; 2.99–7.69%, N = 104–568). All three
isoforms translocated to the plasma membrane upon exposure to
10 min of 1 μM PMA in a subset of cells (50.17% of 291 cells for PKCα,
20.34% of 188 cells for PKCβ, 27.59% of 203 cells for PKCε). Only the
percentage of cells demonstrating translocation of PKCα with baclofen
treatment (9.83%, N = 478) was significantly higher than the percent
of cells demonstrating spontaneous translocation in unstimulated
conditions (2.99%, N = 568; Fisher's exact test, p < 0.0001).
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Figure 5. Activation of GABAB receptors causes translocation of PKCα. (a) Cultured
hippocampal neurons were treated with control media, the phorbol ester phorbol 12myristate 13-acetate (PMA) (1 μM) in media, or baclofen (10 μM) in media for 10 min
before immunostaining. The scale bar in the lower right corner is 20 μm. (b) The
percent cells demonstrating translocation of PKCα, PKCβ, and PKCε in control cultures
(black bars) was compared to the percent cells demonstrating translocation of PKCα,
PKCβ, and PKCε following stimulation with baclofen (gray bars). N = 568, 478, 104,
183, 183, and 177 for the PKCα control, PKCα baclofen, PKCβ control, PKCβ baclofen,
PKCε control, and PKCε baclofen, respectively. *p < 0.001, Fisher's exact test.

Discussion
Previous findings in our lab have shown that in neonatal
hippocampus, GABAB receptor activation decreases calcium current in
a subset of neurons via Gαi/o and enhances L-type calcium current in
other neurons via a non-Gi/o G-protein (Carter and Mynlieff 2004; Bray
and Mynlieff 2011). Despite a variation in percentage of neurons
demonstrating calcium current enhancement (approximately 10% of
neurons in calcium imaging versus 25% in electrophysiology),
knocking down Gαq produced a consistent result – that enhanced
calcium entry could be abolished. The variation in number of cells
which demonstrate enhancement is likely because of the sampling of
every cell within a field during calcium imaging experiments, whereas
sampling in electrophysiology allows the experimenter to pick only the
healthiest, best looking cells. While this percentage may at first appear
low, the hippocampus is composed of no less than 37 different types of
inhibitory interneurons (Ascoli 2013); thus a small percentage could
encompass one or more of these 37 types, many of which have clearly
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delineated functions of their own. While the subset of cells
demonstrating a reduction in calcium current has been attributed to
inhibition of calcium channels by Gαi/o G-proteins, the pathway
describing calcium current enhancement upon GABAB receptor
activation has not previously been explored. The data obtained in this
study support a model in which GABAB receptors couple to Gαq
activating PKCα to cause enhancement of voltage-dependent calcium
current without the involvement of CaMKII (Fig. 6).

Figure 6. The current model for the pathway which begins with GABAB receptor
activation and results in enhanced L-type calcium current. Binding of ligand to the
GABAB receptor leads to activation of a Gαq G-protein, which putatively activates
phospholipase C. The activity of PLC hydrolyses PIP2 into diacylglycerol (DAG) and IP3,
which can activate PKCα. PKCα bypasses calcium/calmodulin-dependent protein kinase
2 (CaMKII) to lead to changes of the L-type calcium channel such that current is
enhanced when the channel opens.

We chose to determine the involvement of Gαq in the pathway
because a similar bidirectional pathway involving both Gαq/11
(mediating calcium current increase) and Gαi/o (mediating calcium
current decrease) was observed in cardiac myocytes (O-Uchi et al.
2008). In addition, activation of Gαq family members (Gαq, Gα11, Gα14,
Gα15/16) are known to activate PKC by stimulating β isoforms of
phospholipase C that hydrolyze phosphatidylinositol bisphosphate
(PIP2), forming inositol tris-phosphate (IP3) and DAG (for review see
(Rhee 2001). DAG and free calcium ions activate PKC, which then
translocates from the cytosol to the cell membrane. Here, PKC may
potentially phosphorylate the L-type calcium channel, either directly or
indirectly through another second messenger. The phosphorylated
channel putatively allows more calcium to enter when the cell is
depolarized; biophysical changes to the channel have not yet been
identified.
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To test the model that Gαq is the G-protein that couples to the
GABAB receptor, the translation of Gαq was inhibited by morpholinos,
synthetic oligonucleotides that bind near the start codon of 5′ mRNA to
inhibit binding of the ribosome. Morpholinos have several advantages
over siRNA for knockdown of protein expression. siRNA are sensitive to
intracellular enzymes, can trigger innate immune responses, and
change the methylation state of DNA (Bayne and Allshire 2005; Judge
et al. 2005; Kawasaki and Taira 2005; Marques and Williams 2005).
None of these things occur with morpholinos (Hudziak et al. 1996) and
they are easily taken up into cultured cells through endocytosis
stimulated by the Endo-Porter peptide. The lack of enzymatic
degradation makes morpholinos particularly useful to knock down
proteins with a relatively long half-life, such as G-proteins. Despite
these advantages, there is only one report of Endo-Porter mediated
morpholino knockdown in mammalian neurons (Chih et al. 2006).
Validation of protein knockdown demonstrated here highlights the
usefulness of this technique.
Western blot analysis indicated that the morpholinos were
efficient in knocking down Gαq in primary hippocampal cultures, but it
was important to verify the specificity of this knockdown. The most
likely candidate for non-specific knockdown would be Gα11 because of
high sequence homology with Gαq. The first 25 coding amino acids
(the site of morpholino binding) are 92% identical. Data shown here
suggest significantly higher expression of Gαq than Gα11 in neonatal
hippocampus, consistent with other reports (Milligan 1993; Ihnatovych
et al. 2002). However, caution must be used in interpreting these
results. Because different antibodies were used to detect each protein,
it is possible that Gα11 antibodies simply give a weaker signal than Gαq
antibodies, even if there is abundant protein. Despite this, we believe
that Gαq is expressed to a relatively higher degree than Gα11, both
because of previous expression data, and the temporal expression
pattern of Gαq. The high expression of Gαq relative to Gα11 makes it the
most likely target of the morpholinos. It is also noteworthy that Gαq is
most highly expressed during the first postnatal week (Ihnatovych
et al. 2002), which corresponds to the time when the highest
percentage of neurons demonstrates calcium current enhancement
with baclofen (Bray and Mynlieff 2009).
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Knockdown of Gαq eliminated the enhancement of calcium
current by GABAB receptors supporting the hypothesis that Gαq is the
G-protein that couples to the GABAB receptor. In addition, confocal
imaging data demonstrated colocalization of Gαq and GABABRs.
Mannoury La Cour et al. (2008) used an antibody-capture/scintillation
proximity assay to show a lack of coupling between Gαq/11 and
GABABRs (2008). However, this work reported the EC50 for baclofen at
approximately 50 μM for Gαi/o coupling. These values are much higher
than those used by others examining Gαi/o activation by GABABRs
(Dolphin and Scott 1986; Sodickson and Bean 1996). Furthermore, the
enhancing effect of baclofen is seen at high nanomolar concentrations
while attenuation requires greater values (Shen and Slaughter 1999).
Thus, it is possible that the assay used by Mannoury La Cour et al.
(2008) is not sensitive enough to show Gαq/GABABR coupling at low
agonist concentrations.
The molecular interaction between the GABAB2 receptor subunit
and Gαi/o involves both the second and third intracellular loops of
GABAB2 (Duthey et al. 2002; Havlickova et al. 2002). This interaction
occurs with the extreme C-terminus of the G-protein (Franek et al.
1999). The lack of sequence homology between Gαi/o and Gαq suggest
that Gαq must couple to the GABAR at sites unique to those examined.
Identifying the sites of direct interaction between the GABABR and Gαq
will support the physiological and colocalization data presented here.
Although this is the first example of Gαq coupling to GABAB receptors,
coupling to more than one G-protein has been shown for other Gprotein coupled receptors, including those that couple to both Gαq and
Gαi/o (Offermanns and Simon 1995; Hawes et al. 2000; Macfarlane
et al. 2001). We believe GABAB receptors to have the same ability,
coupling to both Gαi/o to mediate classic inhibitory responses and Gαq
to mediate calcium current enhancement.
Enhancement of current by GABAB receptors may be mediated
through a number of different mechanisms. It is possible that
activation of GABAB receptors alone is sufficient to open L-type
channels, as shown by Kuczewski et al. (2011). This report showed
that application of 50 μM baclofen without depolarization caused an
increase in calcium entry through L-type channels on the cell surface;
however, we were unable to replicate this effect using the same
concentration of baclofen on our P6–P8 cultured hippocampal neurons
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(data not shown). GABAB receptors have been demonstrated to both
increase and decrease potassium currents by interacting with different
combinations of auxiliary potassium channel tetramerization domaincontaining subunits (Schwenk et al. 2010; Hayasaki et al. 2012).
Hayasaki et al. point out that while these auxiliary subunits are most
likely responsible for the bidirectional response observed, several
factors, including G-protein diversity, may lead to differential effects in
GABAB receptor signaling. Based on data presented here, we believe
GABAB-mediated enhancement of L-type calcium current is because of
its coupling to a Gαq G-protein through a novel pathway, rather than
the canonical Gαi/o pathway. There are, however, other possible
mechanisms for the observed effect. In airway smooth muscle, GABAB
receptor stimulation led to activation of Gαi G-proteins and subsequent
enhancement of calcium current; this study demonstrated that it was
the βγ subunit of the G-protein which activated the same PLC/PKC
pathway as Gαq (Mizuta et al. 2011). However, inhibiting Gαi/o
signaling with pertussis toxin did not eliminate the observed
enhancement in the hippocampus (Bray and Mynlieff 2009). It is also
unlikely that the Gαq βγ subunit may be mediating this effect, because
βγ signaling requires a functional α subunit interaction for proper
assembly (Smrcka 2008). Therefore, while it is possible another
mechanism exists in the GABAB receptor – L-type channel pathway,
the most likely mechanism is GABAB coupling to Gαq.
GABAB-receptor-mediated activation of PKC is not the only
possible pathway involved. Previous studies in our laboratory
examined if calcium current enhancement could be mediated by PKA
(Bray and Mynlieff 2011). In this case, Gαs would likely couple to the
GABAB receptor, leading to a cascade that would result in PKA, either
in addition to or instead of PKC, phosphorylating the calcium channel.
However, because enhancement was so clearly eliminated by
knockdown of Gαq, and because baclofen caused PKC translocation,
this G-protein is involved in mediating current enhancement.
Furthermore, results of experiments designed to inhibit PKA with H-89
were ambiguous in determining a role for PKA in the pathway. Thus,
while PKA (and therefore Gαs) may be involved, we believe Gαq is
responsible for GABAB-mediated calcium current enhancement.
The regulation of L-type calcium channels by PKC has been
reported to both increase and decrease calcium current, and the effect
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on current seems to depend on the isoform of PKC involved. For
example, phosphorylation by PKCε on the N terminus of CaV1.2 L-type
calcium channels inhibits calcium current in cardiac cells (Yue et al.
2004). However, phosphorylation of the C terminus of CaV1.2 by
multiple PKC isoforms in HEK293 cells, including PKCα, led to an
increase in L-type channel activity (Yang et al. 2009). Stimulation of
PKCβII and PKCε with PMA decreased activity of Cav1.3 L-type calcium
channels (Baroudi et al. 2006). Thus, identifying the PKC isoform in
GABAB-mediated L-type current enhancement provides more detailed
information regarding isoform-specific regulation of calcium channels.
We have previously shown that activation of a phorbol estersensitive PKC is required for GABAB-receptor-mediated enhancement
of calcium current (Bray and Mynlieff 2011) and thus, here we sought
to identify which isoform was involved. Of the 15 PKC isoforms
identified only four have been shown to be robustly expressed in the
early neonatal period and only three of these (α, β, and ε) fall into the
categories of conventional or atypical PKCs that respond to phorbol
ester stimulation. All three isoforms showed some basal level of
translocation to the membrane (a measure of activation); however,
only PKCα showed a significant increase in number of neurons showing
translocation when treated with baclofen. Notably, the proportion of
neurons that demonstrated this baclofen-mediated translocation of
PKCα is approximately the same as the proportion that undergoes
current enhancement.
In an effort to describe as complete a pathway as possible, we
examined the involvement of CaMKII in the signal transduction
cascade. Evidence of CaMKII activation by PKC and phosphorylation of
L-type channels in cardiac myocytes (O-Uchi et al. 2008) suggested
that CaMKII may be a component here; however, when neurons were
treated with CaMKII inhibitors Ant-AIP-II (50 nM) or myristolated
CaMKIIntide (250 nM) plus baclofen, a subset of cells still showed
calcium enhancement when depolarized. Although we cannot be sure
that the incubation period was sufficient for the inhibitors to penetrate
the cells at the applied concentration, the data suggest that CaMKII is
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not part of the signaling pathway.
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